These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 625183)

  • 21. Arachidonic acid-dependent activation of benzo[a]pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung.
    Nemoto N; Takayama S
    Carcinogenesis; 1984 Jul; 5(7):961-4. PubMed ID: 6329541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of covalently bound benzo(a)pyrene in chromatin.
    Jahn CL; Litman GW
    Biochem Biophys Res Commun; 1976 May; 76(2):534-40. PubMed ID: 1027444
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of the binding of the carcinogen benzo(a)pyrene to rat liver DNA in vivo by selective induction of microsomal and nuclear aryl hydrocarbon hydroxylase activity.
    Viviani A; Lutz WK
    Cancer Res; 1978 Dec; 38(12):4640-4. PubMed ID: 719642
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative studies on the covalent binding of the carcinogen benzo(a)pyrene to DNA in various model systems.
    Jaggi W; Lutz WK; Schlatter C
    Experientia; 1979 May; 35(5):631-2. PubMed ID: 446661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of epoxide hydrolase activity; effect on the activation of benzo[a] pyrene and its covalent binding to DNA in the nucleus.
    Guenthner TM; Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():705-16. PubMed ID: 6283816
    [No Abstract]   [Full Text] [Related]  

  • 26. Similar level of metabolic activation of benzo(a)pyrene in perfused rat lung and liver and protection of lung by liver in a combined perfusion system.
    Klaus E; Foth H; Kahl R; Kahl GF
    Biochem Biophys Res Commun; 1982 Mar; 105(2):596-602. PubMed ID: 6178407
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of cytochrome P-450-448 inhibitors on the binding of benzo(a)pyrene and derivatives to DNA upon microsomal activation.
    Liu WI; Sloane NH
    Xenobiotica; 1979 Mar; 9(3):165-71. PubMed ID: 38576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covalent binding of benzo[a]pyrene to rat liver cytosolic proteins and its effect on the binding to microsomal proteins.
    Schelin C; Tunek A; Jergil B
    Biochem Pharmacol; 1983 May; 32(9):1501-6. PubMed ID: 6305370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes.
    Keller GM; Turner CR; Jefcoate CR
    Mol Pharmacol; 1982 Sep; 22(2):451-8. PubMed ID: 6292697
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism and DNA binding of benzo(a)pyrene in vivo in the rat.
    Boroujerdi M; Kung H; Wilson AG; Anderson MW
    Cancer Res; 1981 Mar; 41(3):951-7. PubMed ID: 7459882
    [No Abstract]   [Full Text] [Related]  

  • 31. Differences in the binding of stereoisomeric benzo(a)pyrene-7,8-diol-9,10-epoxides to histones in rat liver nuclei.
    Kurokawa M; MacLeod MC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5741-5. PubMed ID: 3931908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of polycyclic hydrocarbons to nuclear components in vitro.
    Vaught J; Bresnick E
    Biochem Biophys Res Commun; 1976 Apr; 69(3):587-91. PubMed ID: 1267804
    [No Abstract]   [Full Text] [Related]  

  • 33. The binding of benzo[alpha]pyrene to DNA does not involve substitution at the 6-position.
    King HW; Thompson MH; Osborne MR; Harvey RG; Brookes P
    Chem Biol Interact; 1976 Mar; 12(3-4):425-8. PubMed ID: 1253339
    [No Abstract]   [Full Text] [Related]  

  • 34. Preferential binding of benzo[a]pyrene into nuclear matrix fraction.
    Hemminki K; Vainio H
    Cancer Lett; 1979 Mar; 6(3):167-73. PubMed ID: 421196
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative and qualitative changes in the metabolism of benzo(a)pyrene in rat tissues after intragastric administration of TCDD.
    Uotila P; Parkki MG; Aitio A
    Toxicol Appl Pharmacol; 1978 Dec; 46(3):671-83. PubMed ID: 746554
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of butylated hydroxyanisole on the metabolism of benzo[a]-pyrene and the binding of metabolites to DNA, in vitro and in vivo, in the forestomach, lung, and liver of mice.
    Ioannou YM; Wilson AG; Anderson MW
    Carcinogenesis; 1982; 3(7):739-45. PubMed ID: 6288282
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of benzo(a)pyrene metabolism by liver and lung microsomal enzymes from 3-methylcholanthrene-treated rhesus monkeys and rats.
    Hundley SG; Freudenthal RI
    Cancer Res; 1977 Sep; 37(9):3120-5. PubMed ID: 406987
    [No Abstract]   [Full Text] [Related]  

  • 38. High-pressure liquid chromatography analysis of benzo(a)pyrene metabolism by microsomal enzymes from rhesus liver and lung.
    Hundley SG; Freudenthal RI
    Cancer Res; 1977 Jan; 37(1):244-9. PubMed ID: 401471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrrolizidine alkaloid-induced alterations in benzo[alpha]pyrene metabolism and binding of benzo[alpha]pyrene metabolites to deoxyribonucleic acid.
    Williams DE; Miranda CL; Buhler DR
    Biochem Pharmacol; 1983 Aug; 32(16):2443-7. PubMed ID: 6311218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of benzo(a)pyrene by human lung microsomal fractions.
    Prough RA; Sípal Z; Jakobsson SW
    Life Sci; 1977 Dec; 21(11):1629-35. PubMed ID: 600015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.